Neogenix Pharmaceuticals Private Limited
About Neogenix Pharmaceuticals Private Limited
Data last updated:
Neogenix Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 23 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74900UP2016PTC140298.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.25 Lakh. It is led by directors Suman Singh and Ankita Srivastva.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at H No. – 632/46/1 Kamta Chinhat, Lucknow, Uttar Pradesh, India – 226028.
As per the financials filed for FY 2023, the company reported a revenue of ₹33.5 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹6,790 (net margin 0.2%) and EBITDA of ₹9,180 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Neogenix Pharmaceuticals has one previous CIN (Corporate Identification Number): U74900DL2016PTC293063. The current CIN is U74900UP2016PTC140298, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900UP2016PTC140298 | Current |
| U74900DL2016PTC293063 | Previous |
Contact details
Neogenix Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. – 632/46/1 Kamta Chinhat, Lucknow, Uttar Pradesh, India – 226028
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Neogenix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neogenix Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Neogenix Pharmaceuticals Private Limited, buy the company report.
Financials of Neogenix Pharmaceuticals Private Limited
FY 2023 filings availableNeogenix Pharmaceuticals Private Limited reported revenue of ₹33.5 Lakh (down 15% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 15% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9,180 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,790 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neogenix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neogenix Pharmaceuticals Private Limited
Neogenix Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Singh | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Ankita Srivastva | Director | 23 Mar 2016 | 10 Years 7 Months | Current |
Auditor
Neogenix Pharmaceuticals Private Limited is audited by RAJAT KUMAR AGRAWAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJAT KUMAR AGRAWAL & CO | FY 2020 | 011288C |
Shareholding
The shareholding of Neogenix Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Neogenix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Neogenix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neogenix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Neogenix Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Neogenix Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Suman Singh ceased to be Additional Director on 31 Dec 2020.
Frequently asked questions
Neogenix Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 23 March 2016 (10+ years old) and is registered under CIN U74900UP2016PTC140298.
Neogenix Pharmaceuticals has 2 current directors:
- Suman Singh - Director
- Ankita Srivastva - Director
The latest financial statements of Neogenix Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Neogenix Pharmaceuticals is U74900UP2016PTC140298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neogenix Pharmaceuticals was incorporated on 23 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Suman Singh ceased to be Additional Director on 31 Dec 2020. Suman Singh was appointed as Director on 24 Aug 2020. Ankita Srivastva was appointed as Director on 23 Mar 2016.
The registered office of Neogenix Pharmaceuticals is at H No. – 632461 Kamta Chinhat, Lucknow, Uttar Pradesh, India – 226028.
Neogenix Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
The compliance status of Neogenix Pharmaceuticals is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.
Neogenix Pharmaceuticals can be reached at its registered office: H No. – 632461 Kamta Chinhat, Lucknow, Uttar Pradesh, India – 226028.